May 23, 2022

ChemLocal.com: new design drugs at low prices: psychostimulators, opiates, Psychedelics, Dissociatives, Cannabinoids and New Chemicals

ChemLocal.com: new chemical research, you can find new legal stimulants, new legal opiates, new legal dissociatives, legal psychedelics, legal marijuana.

ECPLA L-tartrate

ECPLA L-tartrate

ECPLA L-tartrate

ECPLA L-tartrate
ECPLA L-tartrate

ECPLA L-tartrate is a psychedelic drug of the lysergamides class. ECPLA L-tartrate is a structural analogue of LSD and has similar effects, but with increasing dosages it can distort reality and cause hallucinations, as shown in studies on rodents. This drug is little studied and little is known about its pharmacological and toxicological properties.

You can buy ECPLA L-tartrate online right now from our manager as a designer drug for chemical research.

ECPLA L-tartrate
ECPLA L-tartrate
 
Synonyms
  • ECPLA L-tartrate
  • lysergic acid N-ethyl-N-cyclopropylamide hemi-L-tartrate
IUPAC (8β)-N-ethyl-N-cyclopropyl-6-methyl-9,10-didehydroergoline-8-carboxamide hemi-L-tartrate
Formula  
Molecular weight 410.5 g/mol
CAS  
Appearance  
Purity 99 %
Restriction Regulated

ECPLA L-tartrate and all other drugs sold on this website are intended for research and legal applications. ECPLA L-tartrate is a designer drug with obvious physiological and psychoactive effects.

Side effects from ECPLA L-tartrate are not known.

Storage conditions: in a cool and dry place. Terms ECPLA L-tartrate , can last up to 2 years with proper storage conditions.

Price:

We would like to draw your attention to the fact that before you place an order on our website, we checked the legality of the necessary chemicals. The list of permitted chemicals you should know in your country. We did not send orders to Russia, Belarus, Hong Kong, Singapore. We would like you not to order prohibited chemicals in your country.

By purchasing chemical studies on ChemLocal.com you buy a chemical at a wholesale price and get a discount coupon on subsequent purchases on our website.

You may have missed